01—Abstract
Summary
Summary of the 10-Q filed April 30, 2026. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation's quarterly report for the period ended March 31, 2026 shows net operating revenues of $5.368 billiona, up from $5.223 billion a year earlier, with Hospital Operations at $4.048 billion and Ambulatory Care at $1.320 billion.
Results were lifted by a $413 millionb revenue recognized from the termination of the revenue cycle management agreement between Conifer and CHI (now CommonSpirit Health). Operating income rose to $1.296 billion from $943 million, and net income available to Tenet common shareholders was $702 million, or $8.01 diluted earnings per share, compared with $406 million and $4.27 a year earlier. Under the January 2026 Omnibus Agreement with CHI, Conifer redeemed CHI's minority interest for $540 million effective January 1, 2026, and CHI agreed to pay Tenet $1.900 billion in annual installments over three years, with $540 million satisfied by offset.
The filing records a $1.360 billionc non-interest-bearing CHI Note Receivable, of which $395 million sits in other current assets and $828 million in investments and other assets. Operating cash flow was $1.641 billion versus $815 million, aided by $540 million of contract termination payments received. Cash and equivalents rose to $2.967 billion, while purchases of noncontrolling interests totaled $549 million and share repurchases totaled $318 million.
Long-term debt was $13.209 billiond including current portion, and the Credit Agreement's $1.900 billion of borrowing availability was undrawn at March 31, 2026. The filing notes that expiring ACA enhanced premium tax credits and the One Big Beautiful Bill Act could reduce patient volumes and government payments, though the company says it cannot yet estimate the OBBBA impact.
02—Key points
Key Highlights
- Revenue from contract termination of $413 million tied to the Omnibus Agreement with CHI drove much of the quarter's operating income increase to $1.296 billion from $943 million.
- Net income available to Tenet common shareholders was $702 million, or $8.01 diluted EPS, versus $406 million, or $4.27, in the prior-year quarter.
- Net operating revenues rose 2.8% to $5.368 billion, with Ambulatory Care up 10.6% to $1.320 billion and Hospital Operations up 0.5% to $4.048 billion.
- Operating cash flow was $1.641 billion versus $815 million, including $540 million of contract termination payments received from CHI.
- Purchases of noncontrolling interests totaled $549 million, mainly tied to the Conifer redemption of CHI's minority interest, which reduced redeemable noncontrolling interests by $846 million.
- Cash and cash equivalents ended at $2.967 billion, with $1.900 billion available under the undrawn Credit Agreement, against $13.209 billion of total long-term debt.
- The company repurchased 1.346 million shares for $318 million, leaving $1.172 billion available under its share repurchase program.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2026filed April 30, 2026Financial Statements
Q1 FY2026 against Q1 FY2025
| Line item | Q1 FY2026Q1 FY2025 | Change |
|---|---|---|
| Revenue | $5.37B$5.22B | +2.8% |
| Operating Income | $1.30B$943.00M | +37.4% |
| Net Income | $702.00M$406.00M | +72.9% |
| EPS (Basic) | $8.09$4.31 | +87.7% |
| EPS (Diluted) | $8.01$4.27 | +87.6% |
| Shares Outstanding (Basic) | 86.80M94.24M | −7.9% |
| Shares Outstanding (Diluted) | 87.60M95.02M | −7.8% |
05—Questions
Frequently Asked Questions
What drove the large increase in operating income this quarter?
Operating income was $1.296 billion versus $943 million, primarily reflecting $413 million of revenue recognized from the termination of the revenue cycle management agreement between Conifer and CHI, now CommonSpirit Health.
What is the CHI Note Receivable and how is it recorded?
Under the Omnibus Agreement, CHI executed a $1.360 billion non-interest-bearing promissory note payable in three annual installments of approximately $453 million, due January 2027 through January 2029. At March 31, 2026, $395 million was in other current assets and $828 million in investments and other assets, recorded at present value.
How did the CHI transaction affect noncontrolling interests and equity?
The redemption of CHI's minority interest in Conifer, effective January 1, 2026, decreased redeemable noncontrolling interests by $846 million and increased additional paid-in capital by $306 million.
How is the company's liquidity position at quarter end?
Cash and cash equivalents were $2.967 billion, and the Credit Agreement had $1.900 billion of borrowing availability with no cash borrowings outstanding. The company stated its existing sources of liquidity are adequate for current cash needs.
What regulatory risks does the filing highlight?
The filing notes that expired ACA enhanced premium tax credits are expected to reduce patient volumes and payer mix, and that OBBBA provisions beginning in 2027, including Medicaid work requirements and limits on state-directed payments, could materially reduce government program payments. The company said it cannot yet estimate the OBBBA's impact.
06—Continue